Ventyx Biosciences, Inc. (VTYX) Earnings History
Annual and quarterly earnings data from 2019 to 2024
Loading earnings history...
VTYX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
VTYX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export VTYX earnings history in CSV or JSON format
Free sign-in required to download data
Ventyx Biosciences, Inc. (VTYX) Earnings Overview
As of May 8, 2026, Ventyx Biosciences, Inc. (VTYX) reported trailing twelve-month net income of -$107M, reflecting +40.3% year-over-year growth. The company earned $-1.50 per diluted share over the past four quarters.
Looking at the long-term picture, VTYX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2019.
Ventyx Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ARQT (-$2M net income, -4.3% margin), IMVT (-$464M net income), PRAX (-$327M net income), VTYX has comparable earnings metrics. Compare VTYX vs ARQT →
VTYX Earnings vs Peers
Earnings metrics vs comparable public companies
VTYX Historical Earnings Data (2019–2024)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$135M | +30.0% | -$148M | $-1.97 | - | - |
| 2023 | -$193M | -78.0% | -$208M | $-3.30 | - | - |
| 2022 | -$108M | -29.5% | -$113M | $-2.06 | - | - |
| 2021 | -$84M | -197.2% | -$67M | $-1.69 | - | - |
| 2020 | -$28M | -529.9% | -$7M | $-0.56 | - | - |
| 2019 | -$4M | - | -$4M | $-2.29 | - | - |
See VTYX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VTYX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VTYX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVTYX — Frequently Asked Questions
Quick answers to the most common questions about buying VTYX stock.
Is VTYX growing earnings?
VTYX EPS is $-1.50, with earnings growth accelerating to +40.3%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-107M.
What are VTYX's profit margins?
Ventyx Biosciences, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are VTYX's earnings?
VTYX earnings data spans 2019-2024. The accelerating earnings trend is +40.3% YoY. Historical data enables comparison across business cycles.